Tratamiento de la hipertensión arterial en la menopausia

Raúl Emilio Real Delor; Nelson Aquino M.

doi:10.18004/anales/2018.051(01)65-074

Authors

Raúl Emilio Real Delor Dpto. de Medicina Interna. Hospital Nacional. Itauguá, Paraguay
Nelson Aquino M. Servicio de Clínica Médica. Instituto de Previsión Social. Asunción, Paraguay

DOI:

https://doi.org/10.18004/anales/2018.051(01)65-074

Keywords:

Arterial hypertension, Menopause, Paraguay

Abstract

Introduction: Arterial hypertension in menopause is influenced by the decrease in estrogen that induces endothelial dysfunction and increase in body mass index. Objectives: to describe the physiopathological mechanisms of arterial hypertension in menopause and the currently recommended antihypertensive drugs. Methodology: We conducted a literature review in PubMed and SciELO databases using the key words: arterial hypertension and menopause. Results: There are no differences in the response to different antihypertensive drugs and both sexes benefit in the reduction of cardiovascular morbidity and mortality with the reduction of blood pressure. The preventive effectiveness of cardiovascular complications with antihypertensive drugs does not differ according to sex and therefore the choice of medication cannot be based on this criterion in menopausal women. Conclusions: Estrogen deficiency induces endothelial dysfunction and increase in body mass index being the main causes of hypertension in menopause. All antihypertensive drugs are recommended at menopause.

References

1. Vargas Ponce K, Chávez Rondinel N, Taracaya Ugarte D. Tratamiento de la hipertensión arterial en pacientes adultos mayores en atención primaria : ¿existe algún riesgo en la medicación ? An Fac med. 2016;77(3):291–2.

2. Yanes LL, Reckelhoff JF. Postmenopausal hypertension. Am J Hypertens. 2011;24(7):740–9.

3. Ferrucci A, Pignatelli G, Sciarretta S, Tocci G. Hypertension in premenopausal women: Is there any difference? High Blood Press Cardiovasc Prev. 2014;21(3):195–9.

4. Geraci TS, Geraci SA. Considerations in women with hypertension. South Med J. 2013;106(7):434–8.

5. Lima R, Wofford M, Reckelhoff JF. Hypertension in postmenopausal women. Curr Hypertens Rep. 2012;14(3):254–60.

6. Rosano GM, Spoletini I, Vitale C. Cardiovascular disease in women, is it different to men? The role of sex hormones. Climacteric. 2017;20(2):125–8.

7. Maranon R, Reckelhoff JF. Sex and gender differences in control of blood pressure. Clin Sci. 2013;125(7):311–8.

8. Muiesan ML, Salvetti M, Rosei CA, Paini A. Gender Differences in Antihypertensive Treatment: Myths or Legends? High Blood Press Cardiovasc Prev. 2016;23(2):105–13.

9. Ortellado Maidana J, Ramírez A, González G, Olmedo Filizzola G, Ayala de Doll M, Sano M, et al. Consenso Paraguayo de Hipertension Arterial 2015. Rev virtual Soc Parag Med Int setiembre. 2016;3(2):11–57.

10. Di Giosia P, Giorgini P, Stamerra CA, Petrarca M, Ferri C, Sahebkar A. Gender Differences in Epidemiology, Pathophysiology, and Treatment of Hypertension. Curr Atheroscler Rep. 2018;20(3):13.

11. Pacheco-Romero J. Hipertensión arterial en diferentes edades de la mujer. An Fac med. 2010;71(4):257–64.

12. Pimenta E. Hypertension in women. Hypertens Res. 2012;35(2):148–52.

13. Leuzzi C, Modena MG. Hypertension in postmenopausal women: Pathophysiology and treatment. High Blood Press Cardiovasc Prev. 2011;18(1):13–8.

14. Barton M, Meyer MR. Postmenopausal hypertension: Mechanisms and therapy. Hypertension. 2009;54(1):11–8.

15. Kim J-M, Kim T-H, Lee H-H, Lee SH, Wang T. Postmenopausal hypertension and sodium sensitivity. J menopausal Med. 2014;20(1):1–6.

16. Ahmad A, Oparil S. Hypertension in Women: Recent Advances and Lingering Questions. Hypertension. 2017;70(1):19–26.

17. Reckelhoff J. Gender differences in hypertension. Curr Opin Nephrol Hypertens. 2018; 27(0):1–6.

18. Wagner-Grau P. Fisiopatología de la hipertensión arterial. An Fac med. 2010;71(4):225–9.

19. Modena MG. Hypertension in postmenopausal women: How to approach hypertension in menopause. High Blood Press Cardiovasc Prev. 2014;21(3):201–4.

20. Liu Z-M, Woo J, Wu S-H, Ho S. The Role of Vitamin D in Blood Pressure, Endothelial and Renal Function in Postmenopausal Women. Nutrients. 2013;5(7):2590–610.

21. Park S. Age at First Childbirth and Hypertension in Postmenopausal Women. Hypertension. 2017;69(5):821–6.

22. Song L, Shen L, Li H, Liu B, Zheng X, Zhang L, et al. Age at natural menopause and hypertension among middle-Aged and older Chinese women. J Hypertens. 2017;35:1–7.

23. Parikh NI, Norberg M, Ingelsson E, Cnattingius S, Vasan RS, Domellöf M, et al. Association of pregnancy complications and characteristics with future risk of elevated blood pressure: The Västerbotten Intervention Program. Hypertension. 2017;69(3):475–83.

24. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Spencer CC, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Pr. J Am Coll Cardiol. 2017;pii: S0735(17):1–481.

25. Bryce-Moncloa A. Actualización y raciocinio del mejor tratamiento antihipertensivo. An Fac med. 2010;71(4):251–5.

26. Turnbull F, Woodward M, Neal B, Barzi F, Ninomiya T, Chalmers J, et al. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J. 2008;29(21):2669–80.

27. Zilberman JM. Menopausia: Hipertension arterial y enfermedad vascular. Hipertens y Riesgo Vasc. 2018;pii: S1889(17):1–7.

28. Cobin RH, Goodman NF. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on Menopause–2017 Update. Endocr Pract. 2017;23(7):869–80.

29. Sosa Rosado JM. Tratamiento no farmacológico de la hipertensión arterial. An Fac med. 2010;71(4):241–4.

30. Vidalón-Fernandez. A. Clínica de la hipertensión arterial, para el médico general. An Fac med. 2010;71(4):237–9.